bluebird bio

## Overview bluebird bio develops gene therapies using lentiviral vectors to treat severe genetic diseases like thalassemia and sickle cell. Tailored for modern biology and life science teams. ## Key Highlights - FDA-approved ZYNTEGLO and SKYSONA lentiviral gene therapy products. - Pipeline spanning sickle cell, beta-thalassemia, and oncology. - Manufacturing expertise in autologous cell therapy workflows. ## Ideal For - Clinicians evaluating approved gene therapies - Payers and policymakers monitoring outcomes and access - Patients seeking advanced treatments for genetic disorders ## Quick Links - Official site: [bluebirdbio.com](https://www.bluebirdbio.com/) - Add to BioDir collections to track updates and collaborators.